Net profit of Ishita Drugs & Industries declined 26.32% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 6.12% to Rs 3.07 crore in the quarter ended September 2025 as against Rs 3.27 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3.073.27 -6 OPM %5.867.03 - PBDT0.250.28 -11 PBT0.220.25 -12 NP0.140.19 -26 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Ishita Drugs & Industries announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News

Net profit of Ishita Drugs & Industries rose 100.00% to Rs 0.30 crore in the quarter ended June 2025 as against Rs 0.15 crore during the previous quarter ended June 2024. Sales rose 78.22% to Rs 5.40 crore in the quarter ended June 2025 as against Rs 3.03 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales5.403.03 78 OPM %6.485.94 - PBDT0.420.23 83 PBT0.390.20 95 NP0.300.15 100 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News